Thank you for visiting our workgroup page. Here you’ll find information about our collaborative approach to developing solutions to support our vision of enhancing life by ensuring appropriate and personalized use of medication and gene therapies.
We’ve established four workgroups to focus on distinct aspects to getting the medications right™: Practice and Care Delivery Transformation; Payment and Policy Solutions; Precision Medicine Enablement via Advanced Diagnostics; and, Health IT to Support Optimized Medication Use.
Each workgroup has a charter and a framework against which it will develop a set of recommendations that will be included in the GTMRx Blueprint for Change. The workgroups will use a consensus approach to identifying and prioritizing actions necessary to create the systematic transformation that is required to make a difference. They will present their initial recommendations in early 2020.
Workgroup Leadership and Membership
The workgroups are led by representatives from the Board of Directors and Executive Member organizations. Incoming Board of Director and Executive Member organizations can help lead a workgroup to join colleagues in establishing the strategic priorities for that group and offer sponsorship support as needed.
Signing members of the Institute who are passionate about any of these four areas and who are willing to contribute their time and expertise are encouraged to volunteer to be part of a workgroup. There is no cost to becoming a signing member. To learn more about joining the Institute as a signing member, please visit our membership page.
To learn more about each workgroup, please click on the links below. If you have questions and would like to talk with someone at the Institute about the workgroups, please contact Izzy Serji.
Practice & Care Delivery Transformation
This group will provide guidance and recommendations that will enable broad practice adoption of a systematic approach to medication use (CMM) throughout the continuum of care. The group will work to ensure a patient can engage and confidently be assured that the medications or combinations thereof are in fact optimized to meet their unique needs (genetic, personal, social, cultural) within an aligned and constantly “learning” health care delivery system.
Payment and Policy Solutions
This group will offer specific stakeholder guidance and an advocacy platform for GTMRx with strategies for health plans, employers, providers and consumers/consumer groups, together with specific recommendations for overcoming payment and policy barriers that inhibit broad adoption of a systematic approach to appropriate medication use and access across the health care continuum.
Precision Medicine Enablement via Advanced Diagnostics
This group will engage existing groups to determine major barriers or opportunities for advancement; consider employer, government, and health plan payer needs to develop a framework for adoption of testing and use; and educate providers (physicians, pharmacists, nursing and others).
Health IT to Support Optimized Medication Use
This group will provide leadership guidance and recommendations to enable broad practice adoption of a systematic approach to medication use (CMM) throughout the continuum of care. Success will be defined as increased adoption of current and future standards of practice that provide optimal outcomes for consumers through effective medical and pharmaceutical management.